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Innervation Patterns in the Renal Artery Ostium May Limit the Efﬁcacy of
Endovascular Radiofrequency Ablation
Abraham R. Tzafriri1, Felix Mahfoud2, John Keating3, Peter Markham1,
Anna-Maria Spognardi3, Gee Wong3, Kristine Fuimaono4, Elazer Edelman5
1CBSET Inc., Lexington, MA, 2Saarland University Hospital, Homburg/Saar,
Germany, 3CBSET, Inc., Lexington, MA, 4Cordis/Biosense Webster, Inc. a Johnson &
Johnson Company, Irwindale, CA, 5Harvard-MIT Biomedical Engineering Center,
Cambridge, MA
Background: Unconﬁrmed anecdotal evidence suggests that the superior aspect of the
renal artery ostium is an attractive target for endovascular ablation.
Methods: Nerve and ganglion distribution was characterized in 16 renal arteries at 3
discrete distances from the aorta (Fig 1). RF ablation was performed in the renal
ostium of another 8 arteries using a prototype renal/crescent multi-electrode RF
catheter (Biosense Webster, CA) & treatments were conﬁrmed by angiography. Renal
norepinephrine (NEPI) levels were correlated with ablation zone geometries & nerve
and ganglia injury 7d post denervation.
Results: Nerves & ganglia were more abundant but more distant from the lumen at
locations closest to the aorta (Fig 1). At all 3 distances from the aorta, nerves and ganglia
were distributed across all 4 quadrants. Efﬁcacy was observed in 1 of 8 treated arteries
where ablation area was 99.1mm2 & involved all 4 quadrants at a maximal depth of
9.1mm affecting 50% of nerves & reducing NEPI (37ng/g). In the other 7 arteries, no
efﬁcacy was observed, fewer than 20% of the nerves were affected, the ablation areas
were smaller (16.210.9mm2) & present in only 1-2 quadrants at maximal depths of
3.82.7mm, and renal NEPI levels remained at baseline (620-991ng/g). Half of ablation
zones did not contain ganglia, and the rest only 1 or 2 ganglia.Conclusions: Renal denervation therapies which speciﬁcally target the renal ostium
must account for the unique anatomy and treatments localized to the superior aspect of
the ostium alone will likely have limited added beneﬁt as nerves are present in all
quadrants.
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System: Preclinical Safety Evaluation Through 180 Days
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Background: Abipolarmulti-electrode 7 Fr-compatible balloon catheter radiofrequency
(RF) renal denervation system (Vessix, Boston Scientiﬁc, Natick, MA) with short pro-
cedure time was evaluated in a preclinical safety study in a domestic swine model.
Methods: Renal arteries of 27 swine received whole-artery treatment with over-
lapping treatments in the proximal 12 mm to mimic balloon overlap. Each of 3 his-
topathology cohorts (30, 90, 180 day follow-ups) had 4 RF-treated and 3 sham-treated
(no RF energy delivered) animals; response of artery and surrounding nerves to
bilateral treatment was examined (42 arteries). Scanning electron microscopy (SEM)
was used to examine the renal artery ﬂow surface for endothelialization in an addi-
tional 6 pigs (3 at each of 30 and 90 days: 12 arteries) following unilateral whole-
artery treatment with proximal overlap: RF on one side and sham on the other. Power
wasw1 watt, treatment duration 30 seconds, target temperature 68C. Histology was
done on all 54 kidneys and assessment for off-target injury was done in all 27 swine.
Results: One pig died due to spiral colon torsion unrelated to the device at 131 days,
resulting in 6 arteries evaluated for the 180 day cohort. Renal artery injury was
transmural and segmental, typically involving 30-60% of the circumference and
demonstrating overlying nerve injury and associated segmental neointimal hyperplasia
which was hemodynamically trivial (maximum stenosis 17.7% in any section).
Healing of necrotic arterial media was by replacement ﬁbrosis, essentially complete at
90 days and unchanged at 180 days. Overlying nerves also became ﬁbrotic with no
evidence of regeneration at 180 days by conventional histology. Endothelialization
was focally incomplete at 30 days but conﬂuent at 90 days. Sham-treated arteries
showed only focal mechanical injury also seen with RF treatment. Kidney histologyJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Nedemonstrated no injury and there was also no injury to renal veins, ureters, adrenal
glands, psoas muscles, peritoneum or intestine.
Conclusions: Safety of the Boston Scientiﬁc Vessix Renal Denervation System in 7F
conﬁguration was demonstrated for both single and overlap treatment.
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Second generation devices for renal denervation give better renal blood ﬂow
when compared with 1st generation catheters
Waleed Kadro1, Maya Turkmani1, Hussam Rahim1, Cathy John1, Zaid Zaki1,
Gina Pietro1, Amr Alkarmi1, Fares Alahdab1
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Background: Renal Denervation (RDN) is an effective treatment for resistant hy-
pertension. The procedure was done ﬁrst with a single electrode catheter creating
multiple intentionally spaced lesions. The catheter delivers 4-6 radiofrequency (RF)
ablations at points distributed along the length of the renal artery. The procedure
requires rotation and pull-back of the catheter between each hit. Second generation
devices enable multiple simultaneous ablations at different points, allowing a single
hit. RF is applied with pre-programmed time and intensity. The system provides same
power regardless of catheter size eliminating the need for adjustment of the level. This
gives a more predictable lesion pattern with single hit and a shorter time. This may
reduce the risk of overheating and clot formation during RF delivery. The effect of
RDN on renal blood ﬂow (RBF) and the safety of the two generations of devices
haven’t been compared. We report the effect of those devices on RBF by using the
method of renal frame count (RFC).
Methods: We studied the (RBF) before and after RDN by counting the numbers of
frames (fr)on the renal angiogram from a beginning fr to an end fr. Fr1 is the fr that
shows both edges of the ostium of the renal artery immediately after contrast injection.
The end fr the fr which shows the contrast when it has reached the lateral edge of the
renal cortex. RFC was calculated before and immediately after RDN in 10 cases done
using 1st generation device. The results were compared with another 10 cases done
using 2nd generation device.
Results: The mean RFC was 9.28 fr before RDN and increased to 13.71 fr after RDN
in the cases that used 1st generation device (p< 0.001) suggesting slower (RBF) after
RDN. The mean RFC was 9.44 fr before RDN and remained unchanged after the
procedure in the cases that used 2nd generation device (p¼0.759) suggesting no
signiﬁcant changes in (RBF) after the procedure.
Conclusions: 1st generation device causes signiﬁcant increase in RFC reﬂecting
deterioration in RBF when compared with 2nd generation. This can be explained by
distal embolization due to catheter manipulation and micro clots formation from blood
ovweheating due to loss of direct contact with intima.New Devices and Innovation
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First Percutaneous Transluminal Caval ﬂow Restriction in a Patient with
Congestive Heart Failure
Jose E. Herrera1, Jose A. Herrera1, Igor F. Palacios2
1Ascardio, Barquisimeto, Venezuela, 2Massachusetts General Hospital, Boston, MA
Background: So far, preload reduction in patients with Congestive Heart Failure
(CHF) is performed by the use of high potency diuretics. We have previously reported
that a Dynamic Stenosis of Inferior Vena Cava (IVC) associated with beneﬁcial he-
modynamic changes occurs, in some patients with CHF. Here, we are reporting one
case of intermittent preload reduction by the use of an inﬂated balloon placed in the
high IVC and guided by respiratory phases resulting in total occlusion during inspi-
ration and subtotal occlusion during expiration.
Methods: 66 years-old Female patient with ischemic heart failure with severe left
ventricular (LV) dysfunction (EF 39%), severe diastolic dysfunction with high LV
ﬁlling pressure, NYHA class 2B, angina, scheduled for coronary angiogram. The
patient was screened and enrolled in our caval ﬂow protocol trial. An IVC balloon
catheter for venous occlusion was introduced via right femoral vein, and was inﬂated
up to 10 mm before the drainage of the Hepatic veins in the IVC. The IVC velocity
was measured at 2 cm from the right atrium and caval ﬂow velocity was 1.08 m/s, and
then was inﬂated up to 13 to 14 mm achieving caval ﬂow velocity up to 1.28 m/sec.
The balloon remained inﬂated for 25 min.
Results: Right heart pressures and echocardiographic measurements showed: 44%
reduction in pulmonary capillary pressure, 38% right ventricular pressure, and 60%
reduction of the right atrium pressure compared with baseline. The LV diastolic
diameter was reduced by 8% and systolic diameter decreased 18%, Ee’ was reducedw Devices and Innovation B125
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comby 20% indicating reduction of LV ﬁlling pressure, the LVEF by Teicholz increased
from 39% up to 45% (15%), by Simpson decreased from 45% to 40% by reducing
8.8%, cardiac output decreased from 2.61 l/min to 2.31 l/min during balloon
inﬂation.
Conclusions: We are reporting the ﬁrst experience in humans of a new method for
intermittent preload reduction in patients with CHF. The beneﬁcial hemodynamic and
echocardiographic changes obtained in this patient suggest that this new procedure
may play role in the treatment of patients with CHF. Large studies are needed to
further evaluate this new procedure.
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Fetal Pulmonary Valvuloplasty. In-Utero and Post-Natal Outcomes
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Background: There is a paucity of data regarding the feasibility, safety and efﬁcacy
of fetal pulmonary valvuloplasty (FPV) for pulmonary atresia or stenosis with intact
interventricular septum (PA/PS/IVS) and evolving hypoplastic right heart syndrome
(HRHS) diagnosed in-utero. We report in-utero and post natal outcomes of this
procedure.
Methods: FPV was performed under maternal spinal anesthesia and fetal general
anesthesia by a multi-disciplinary team under echo monitoring. A 15 cm long 17 G
Chiba needle was used to access the apex of the RV. The pulmonary valve (PV) was
perforated (when atretic) either with the needle or using a stiff coronary wire. Pre-
mounted systems with coronary balloons (1.2-1.5 times the valve annulus) over
coronary wires were advanced.
Results: From 01/08, 10 fetuses (6 PS/ 4 PA; mean age: 27  2 weeks) underwent
11 procedures. There were 2 failures 2. One had a successful repeated procedure
2 weeks afterwards. There were no maternal complications. The valve was suc-
cessfully crossed and dilated in 9 with echo evidence of forward ﬂow and pulmonary
insufﬁciency. Ductal spasm was observed in 4. Pericardial effusion requiring
drainage was observed in all but one patient. One patient was born at elsewhere and
underwent a BTT shunt and is now 3 months. Two fetuses are still in-utero. Six
patients were born at our center and underwent neonatal pulmonary valvuloplasty
and ductal stenting and were followed over a median post-natal period of 12 months
(6-48). In these patients there was a signiﬁcant and progressive increase in RV size
(Z value of the TV, RV length) from the initial in-utero to the last echo assessment
and all achieved an eventual BVC and spontaneous closure of the ductal stent with
Sats > 90%.
Conclusions: FPV followed by neonatal valvuloplasty and ductal stenting was an
effective means to achieve adequate RV growth and a BVC in fetuses with PA/PS/IVS
and evolving HRHS. FPV is technically demanding and frequently results in peri-
cardial effusion requiring drainage. The procedure seems to be safe to the mother.
More patients are needed to draw stronger conclusions.
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A Long Term Lumen Remodeling Analysis of a Novel Non-Drug Eluting
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Background: Degradation of bioabsorbable stents (BAS) has been shown to allow
restoration of the treated segment’s plasticity and reactivity to those resembling a non-
stented artery, a desirable feature unattainable with metallic stents (BMS). We aimed
to evaluate by OCT the long term dynamic changes in arterial geometry in response to
a novel non-drug eluting BAS as compared to BMS.
Methods: Thirty-ﬁve coronary arteries of 13 swine received BAS (Amaranth Medical,
Mountain View, CA n¼22) or BMS (Liberte Boston Scientiﬁc, Natick, MA n¼13).
Optical coherence tomography (OCT) was done at day 0, day 28 (BAS, n¼22; BMS,
n¼13), 1 year and 2 years (BAS, n¼6; BMS, n¼4).
Results: The lumen areas of reference segments increased over time, but less for the
BMS-caged segments (Day 0¼6.11.8mm2, 2 Years¼10.62.9mm2) than for the
BAS-treated arteries (Day 0¼6.71.9mm2, 2 Years¼12.10.4mm2). BMS showed
lumen area loss at 28 days as expected due to neointimal formation, and then minimal
lumen area variance over time up to 2 years (Day 0¼6.791.7mm2, 2
Years¼6.782.25mm2). In contrast, in BAS the early lumen area loss present at 28
days inverted into lumen gain that corresponded with the scaffold mechanics paral-
leling the artery growth and allowing the treated segment to remodel (Day
0¼7.310.9mm2, 2 Years¼9.711.58mm2, Figure).B126 JACC Vol 64/11/Suppl B jConclusions: Restoration of the treated segment’s ability to grow and remodel, with
late lumen area gain as a consequence, appear to be a reproducible and inherent
pattern of non-drug eluting bioabsorbable stent behavior in the porcine coronary
model.
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Long-term Angiographic and Optical Coherence Tomography Follow-up of
XINSORB Scaffold in Porcine Coronary Model
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Background: We designed the ﬁrst poly-L-lactic acid XINSORB scaffold in China.
Long-term morphological results of this kind of scaffold were explored in a porcine
coronary model.
Methods: XINSORB scaffold (3.0mm in diameter and 15mm in length) were
implanted into porcine coronary arteries with a reference vessel diameter ranging from
2.5 to 2.8mm, using a 1.1:1 stent-to-artery ratio. Angiogram and optical coherence
tomography (OCT) test were performed after implantation and at 1, 3, 12, and 18-
month follow-up.
Results: Total 28 mini pigs were enrolled and 56 scaffolds were deployed. At 1, 3, 12,
and 18-month, 8, 8, 10, and 10 scaffolds were examined respectively. Angiogram after
procedure showed that proximal, in-scaffold, and distal minimal luminal diameter
were 2.930.28mm, 2.780.26mm and 2.730.30mm. The corresponding percent-
age of diameter stenosis (%DS) was 5.74.0%, 7.04.1% and 6.74.1% respec-
tively. At 1-month follow-up, proximal, in-scaffold, and distal late luminal loss (LLL)
of scaffold were 0.530.41mm, 0.680.42mm and 0.650.24mm, while %DS were
9.57.7%, 17.616.8% and 10.57.4%. At 3-month, proximal, in-scaffold, and
distal LLL were 0.230.48mm, 0.770.48mm and 0.110.35mm, while %DS were
14.59.4%, 31.913.6% and 5.43.6%. At 12-month, proximal, in-scaffold, and
distal LLL were -0.130.45mm, 0.280.41mm and 0.180.48mm, while %DS were
2.42.9%, 14.19.1% and 8.68.7%. At 18-month, proximal, in-scaffold, and distal
LLL were 0.370.57mm, 0.090.31mm and -0.010.41mm, while %DS were
3.94.6%、13.77.3% and 6.95.2%. OCT demonstrated that luminal area, scaffold
area, neointimal area and percentage of area stenosis were 5.951.63mm2,
8.081.16mm2, 2.120.67mm2 and 25.810.6% at 1 month, 4.020.96mm2,
7.910.53mm2, 2.890.45mm2 and 37.99.7% at 3 month, 5.960.82mm2,
8.090.74mm2, and 2.070.36mm2 and 24.17.3% at 12 month and
6.840.77mm2, 8.740.82mm2, 1.940.56mm2 and 19.76.9% at 18 month.
Preserved box of scaffold was 100%, 97.6%, 92.1% and 89.4% at each time point.
Conclusions: Neointimal hyperplasia of XINSORB scaffold was prominent at 3-
month. After that, LLL and %DS were noticeably reduced. LA at 18-month was
signiﬁcantly larger than that at 3-month with a constant scaffold area.
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Acute Left Ventricular Unloading and Delayed Coronary Reperfusion Promotes
Stromal Cell Derived Factor-1 (SDF-1) Expression and Cardioprotective
Signaling in Acute Myocardial Infarction
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Background: Ischemia-reperfusion injury (IRI) remains a major determinant of
mortality in acute myocardial infarction (AMI). Stromal cell-derived factor-1 (SDF-1)
is a chemokine that promotes myocardial salvage by activating cardioprotective
signaling via Akt, ERK, and STAT-3. No studies have targeted initially reducing left
ventricular stroke work (LVSW) to limit IRI in AMI. The Impella CP axial-ﬂow pump
reduces LVSW. We tested the hypothesis that ﬁrst reducing myocardial work and
delaying coronary reperfusion reduces infarct size by activating cardioprotective
signaling pathways.
Methods: AMI was induced by occlusion of the left anterior descending artery (LAD)
via angioplasty for 90 minutes in 50kg male Yorkshire swine (n¼5/group). In Group
1, the LAD was reperfused for 120 minutes. In Group 2, after 90 minutes of ischemia
the Impella CP device was activated and the LAD left occluded for an additional 60
minutes (150 minutes of LAD occlusion total), followed by 120 minutes of reperfu-
sion. The Impella CP was active throughout reperfusion. Western blot analysis
quantiﬁed myocardial kinase activity.September 13–17, 2014 j TCT Abstracts/New Devices and Innovation
